Lyell Immunopharma, Inc. COM is a security (CUSIP 55083R104) tracked across SEC portfolio filings. 2 institutional managers reported $14.8M on Form 13F as of 2026-03-31.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Decheng Capital LLC | MENLO PARK, CA | $13.9M | 692,050 |
| TAKEDA PHARMACEUTICAL CO LTD | Tokyo, M0 | $891K | 54,887 |